Great Lakes Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.36M Sell
14,888
-957
-6% -$315K 0.04% 259
2025
Q4
$5.55M Sell
15,845
-218
-1% -$73.7K 0.05% 213
2025
Q3
$5.19M Sell
16,063
-869
-5% -$270K 0.04% 245
2025
Q2
$6.59M Sell
16,932
-588
-3% -$237K 0.06% 242
2025
Q1
$7.62M Sell
17,520
-579
-3% -$232K 0.07% 220
2024
Q4
$6.68M Sell
18,099
-2,705
-13% -$1.13M 0.06% 259
2024
Q3
$10.8M Buy
20,804
+1,811
+10% +$967K 0.09% 195
2024
Q2
$10.3M Buy
18,993
+1,149
+6% +$607K 0.09% 197
2024
Q1
$9.25M Buy
17,844
+1,683
+10% +$837K 0.08% 219
2023
Q4
$7.62M Sell
16,161
-2,070
-11% -$957K 0.07% 239
2023
Q3
$7.94M Buy
18,231
+177
+1% +$80.3K 0.07% 229
2023
Q2
$8.02M Sell
18,054
-90
-0.5% -$41.5K 0.08% 234
2023
Q1
$8.34M Sell
18,144
-2,063
-10% -$982K 0.08% 253
2022
Q4
$1.04M Buy
20,207
+911
+5% +$463K 0.06% 417
2022
Q3
$8.77M Sell
19,296
-210
-1% -$100K 0.19% 144
2022
Q2
$9.41M Buy
19,506
+2,506
+15% +$1.24M 0.19% 140
2022
Q1
$8.35M Buy
17,000
+8,859
+109% +$4.05M 0.14% 182
2021
Q4
$3.77M Buy
8,141
+488
+6% +$205K 0.06% 301
2021
Q3
$2.85M Sell
7,653
-140
-2% -$53.2K 0.04% 335
2021
Q2
$2.98M Buy
7,793
+378
+5% +$144K 0.04% 338
2021
Q1
$2.66M Sell
7,415
-2,622
-26% -$843K 0.04% 344
2020
Q4
$3.22M Buy
10,037
+1,229
+14% +$377K 0.06% 308
2020
Q3
$2.37M Sell
8,808
-193
-2% -$51.9K 0.05% 317
2020
Q2
$2.37M Sell
9,001
-350
-4% -$93.4K 0.06% 313
2020
Q1
$2.12M Sell
9,351
-38,266
-80% -$10.4M 0.06% 295
2019
Q4
$14.4M Buy
47,617
+3,681
+8% +$1.01M 0.31% 81
2019
Q3
$10.5M Sell
43,936
-3,297
-7% -$903K 0.23% 110
2019
Q2
$13.3M Buy
47,233
+8,259
+21% +$2.26M 0.29% 79
2019
Q1
$11.2M Buy
38,974
+6,826
+21% +$1.97M 0.25% 104
2018
Q4
$8.44M Sell
32,148
-23,796
-43% -$6.54M 0.2% 122
2018
Q3
$15.3M Buy
55,944
+19,423
+53% +$5.04M 0.34% 60
2018
Q2
$8.69M Buy
36,521
+25,501
+231% +$5.91M 0.2% 114
2018
Q1
$2.42M Buy
11,020
+1,318
+14% +$310K 0.06% 289
2017
Q4
$2.18M Sell
9,702
-494
-5% -$105K 0.05% 307
2017
Q3
$1.94M Sell
10,196
-125
-1% -$23.8K 0.05% 307
2017
Q2
$1.94M Sell
10,321
-324
-3% -$58.2K 0.05% 290
2017
Q1
$1.76M Sell
10,645
-1,357
-11% -$216K 0.05% 289
2016
Q4
$1.73M Sell
12,002
-231
-2% -$30.9K 0.05% 285
2016
Q3
$1.53M Sell
12,233
-1,200
-9% -$155K 0.04% 303
2016
Q2
$1.76M Sell
13,433
-776
-5% -$106K 0.05% 299
2016
Q1
$1.98M Sell
14,209
-1,896
-12% -$253K 0.05% 271
2015
Q4
$2.25M Sell
16,105
-10,059
-38% -$1.39M 0.07% 230
2015
Q3
$3.66M Sell
26,164
-51,260
-66% -$7.7M 0.11% 154
2015
Q2
$12.7M Sell
77,424
-8,707
-10% -$1.39M 0.39% 56
2015
Q1
$13.3M Sell
86,131
-50,002
-37% -$7.12M 0.41% 56
2014
Q4
$17.1M Buy
136,133
+64,100
+89% +$7.92M 0.53% 48
2014
Q3
$8.62M Buy
72,033
+69,292
+2,528% +$7.95M 0.29% 69
2014
Q2
$295K Buy
+2,741
New +$282K 0.01% 300

Other funds holding ELV

Great Lakes Advisors's ELV Position: Q1 2026 in Review

Great Lakes Advisors reduced its Elevance Health (ELV) stake by 6% in Q1 2026, selling an estimated $315K and leaving 14,888 shares worth $4.36M. The position accounts for 0.04% of the portfolio, ranked #259.

Great Lakes Advisors first reported a position in ELV in Q2 2014 and has held it in 48 quarters since. The position peaked at $17.1M in Q4 2014. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Great Lakes Advisors held 14,888 shares of Elevance Health worth $4.36M as of Q1 2026.
  • Great Lakes Advisors sold 957 Elevance Health shares in Q1 2026, an estimated $315K.
  • Elevance Health made up 0.04% of Great Lakes Advisors's portfolio in Q1 2026, its #259 holding.
  • Great Lakes Advisors first reported a position in Elevance Health in Q2 2014 and has held it in 48 quarters since.
  • Great Lakes Advisors's Elevance Health position peaked at $17.1M in Q4 2014.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Great Lakes Advisors's 13F filing for Q1 2026, filed 12 May 2026.